Antiviral Res

1. MARTIN HJ, Melo-Filho CC, Korn D, Eastman RT, et al
   Small molecule antiviral compound collection (SMACC): A comprehensive, highly curated database to support the discovery of broad-spectrum antiviral drug molecules.
   Antiviral Res. 2023;217:105620.
   

   >> Share

   
   

   
   BMJ

2. 
   The UK government needs to expand covid-19 vaccination this winter.
   BMJ. 2023;382:p2006.
   

   >> Share

   
   
3. IACOBUCCI G
   Covid-19 and flu boosters to start earlier than planned, with extra funding for GPs.
   BMJ. 2023;382:p2004.
   

   >> Share

   
   
4. DYER O
   Covid-19: US doctors sue regulator for charging them with spreading misinformation in pandemic.
   BMJ. 2023;382:1991.
   

   >> Share

   
   
5. RIMMER A
   Covid-19: Families sue former health secretary over care home and hospital deaths.
   BMJ. 2023;382:1981.
   

   >> Share

   
   
6. HARWOOD RH, Goldberg SE, Brand A, van Der Wardt V, et al
   Promoting Activity, Independence, and Stability in Early Dementia and mild cognitive impairment (PrAISED): randomised controlled trial.
   BMJ. 2023;382:e074787.
   

   >> Share

   
   

   
   Clin Infect Dis

7. WONG CKH, Lau KTK, Au ICH, Lau EHY, et al
   Comparison of bivalent and monovalent mRNA vaccine boosters.
   Clin Infect Dis. 2023 Aug 30:ciad519. doi: 10.1093.
   

   >> Share

   
   
8. LAM T, Saso A, Ortiz AT, Hatcher J, et al
   The Socio-Economic and Demographic Risk Factors for SARS-CoV-2 Seropositivity Among Healthcare Workers in a UK Hospital: A Prospective Cohort Study.
   Clin Infect Dis. 2023 Aug 30:ciad522. doi: 10.1093.
   

   >> Share

   
   
9. GRIGGS EP, Mitchell PK, Lazariu V, Gaglani M, et al
   Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 States, June 2021-March 2023.
   Clin Infect Dis. 2023 Aug 26:ciad505. doi: 10.1093.
   

   >> Share

   
   

   
   Emerg Infect Dis

10. DU Z, Wang Y, Bai Y, Wang L, et al
    Estimate of COVID-19 Deaths, China, December 2022-February 2023.
    Emerg Infect Dis. 2023;29.
    

    >> Share

    
    
11. CHAN YLE, Irvine MA, Prystajecky N, Sbihi H, et al
    Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada.
    Emerg Infect Dis. 2023;29.
    

    >> Share

    
    
12. MNDALA L, Chapuma C, Riches J, Gadama L, et al
    Effects of COVID-19 on Maternal and Neonatal Outcomes and Access to Antenatal and Postnatal Care, Malawi.
    Emerg Infect Dis. 2023;29.
    

    >> Share

    
    
13. NABITY SA, Marks SM, Goswami ND, Smith SR, et al
    Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States.
    Emerg Infect Dis. 2023;29.
    

    >> Share

    
    

    
    Int J Infect Dis

14. DIEXER S, Klee B, Gottschick C, Xu C, et al
    Association between Virus Variants, Vaccination, Previous Infections, and Post COVID-19 Risk.
    Int J Infect Dis. 2023 Aug 25:S1201-9712(23)00702.
    

    >> Share

    
    
15. YAN X, Li K, Lei Z, Luo J, et al
    Prevalence and associated outcomes of co-infection between SARS-CoV-2 and influenza: a systematic review and meta-analysis.
    Int J Infect Dis. 2023 Aug 28:S1201-9712(23)00705.
    

    >> Share

    
    
16. HAUTEFORT C, Corre A, Poillon G, Jourdaine C, et al
    Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients: Results of a randomized controlled trial.
    Int J Infect Dis. 2023 Aug 29:S1201-9712(23)00707.
    

    >> Share

    
    

    
    Intensive Care Med

17. OPPERHUIZEN AL, van Lier IMJ, Hartmeyer SL, Aarts MPJ, et al
    Effectiveness of blue light-emitting glasses for intensive care unit health care workers on night shifts during the COVID-19 pandemic.
    Intensive Care Med. 2023 Aug 30. doi: 10.1007/s00134-023-07175.
    

    >> Share

    
    

    
    J Infect

18. SHARMA SN
    Did the Black Death Give Birth to the Healthcare Hero?
    J Infect. 2023 Aug 25:S0163-4453(23)00460-7. doi: 10.1016/j.jinf.2023.
    

    >> Share

    
    
19. GUAN X, Huang Q, Dong M, Li M, et al
    SARS-CoV-2-specific antibody and T-cell immunity in convalescents after infection wave in Beijing in late 2022.
    J Infect. 2023 Aug 29:S0163-4453(23)00462-0. doi: 10.1016/j.jinf.2023.
    

    >> Share

    
    

    
    J Med Virol

20. LIAO HC, Huang MS, Chiu FF, Chai KM, et al
    Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2.
    J Med Virol. 2023;95:e29040.
    

    >> Share

    
    
21. YANG H, Wang Z, Zhang Y, Xu M, et al
    Clinical characteristics and factors for serious outcomes among outpatients infected with the Omicron subvariant BF.7.
    J Med Virol. 2023;95:e28977.
    

    >> Share

    
    
22. GUTERRES A
    Viral load: We need a new look at an old problem?
    J Med Virol. 2023;95:e29061.
    

    >> Share

    
    
23. SILVA MFS, de Oliveira FCE, Pinto ACMD, Luciano MCDS, et al
    Antibody response following the fourth SARS-CoV-2 vaccine dose during the Omicron wave in Brazil.
    J Med Virol. 2023;95:e29055.
    

    >> Share

    
    
24. ZHOU H, Xie P, Qiu M, Dong S, et al
    Arbidol increases the survival rate by mitigating inflammation in suckling mice infected with human coronavirus OC43 virus.
    J Med Virol. 2023;95:e29052.
    

    >> Share

    
    
25. SENGUPTA S, Shaw SK, Chatterjee S, Bhattacharya G, et al
    Perturbations in spike-specific peripheral T follicular helper cells in SARS-CoV2 breakthrough convalescent individuals immunized by BBV152 vaccine.
    J Med Virol. 2023;95:e29053.
    

    >> Share

    
    
26. 
    Correction to "Safety and immunogenicity of COVID-19 vaccination in patients with hepatocellular carcinoma (CHESS-NMCID 2101): A multicenter prospective study".
    J Med Virol. 2023;95:e29063.
    

    >> Share

    
    

    
    J Virol

27. GUO H, Li A, Dong TY, Si HR, et al
    Isolation of ACE2-dependent and -independent sarbecoviruses from Chinese horseshoe bats.
    J Virol. 2023 Sep 1:e0039523. doi: 10.1128/jvi.00395.
    

    >> Share

    
    

    
    JAMA

28. HARRIS E
    CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant.
    JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16105.
    

    >> Share

    
    
29. HARRIS E
    Severe COVID-19 Linked to Enduring Immune System Changes.
    JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16109.
    

    >> Share

    
    
30. KENTISH-BARNES N, Resche-Rigon M, Lafarge A, Souppart V, et al
    PTSD Symptoms Among Family Members of Patients With ARDS Caused by COVID-19 After 12 Months.
    JAMA. 2023 Sep 1. doi: 10.1001/jama.2023.15879.
    

    >> Share

    
    

    
    Lancet

31. KUNG S, Hills T, Kearns N, Beasley R, et al
    New Zealand's COVID-19 elimination strategy and mortality patterns.
    Lancet. 2023 Aug 24:S0140-6736(23)01368-5. doi: 10.1016/S0140-6736(23)01368.
    

    >> Share

    
    
32. DAI L, Duan H, Liu X, Zhou H, et al
    Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection.
    Lancet. 2023;402:687-689.
    

    >> Share

    
    

    
    Nature

33. ADDETIA A, Piccoli L, Case JB, Park YJ, et al
    Neutralization, effector function and immune imprinting of Omicron variants.
    Nature. 2023 Aug 30. doi: 10.1038/s41586-023-06487.
    

    >> Share

    
    
34. OZA A
    COVID infection risk rises the longer you are exposed - even for vaccinated people.
    Nature. 2023 Aug 30. doi: 10.1038/d41586-023-02715.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share